Regain Biosurgery team designed a novel hemostatic product based on "nanomedical" materials, namely, polyurethane nanoparticles (PU NPs). PU NP has been proved to exhibit anti-inflammatory effect in vitro, and product prototype has been demonstrated to induce almost no foreign body reactions and probably exhibit neuroprotective effects in vivo.